These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 25815475)

  • 1. A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C).
    Smith GA; Rocha EM; Rooney T; Barneoud P; McLean JR; Beagan J; Osborn T; Coimbra M; Luo Y; Hallett PJ; Isacson O
    PLoS One; 2015; 10(3):e0121072. PubMed ID: 25815475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Stayte S; Rentsch P; Li KM; Vissel B
    PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease.
    Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1141-1150. PubMed ID: 31408200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease.
    Parra I; Martínez I; Ramírez-García G; Tizabi Y; Mendieta L
    Neurotox Res; 2020 Jan; 37(1):1-11. PubMed ID: 31478124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease.
    Singh S; Mishra A; Mohanbhai SJ; Tiwari V; Chaturvedi RK; Khurana S; Shukla S
    Free Radic Biol Med; 2018 Dec; 129():73-87. PubMed ID: 30176346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-triggered effects of the microbubbles coupled to GDNF- and Nurr1-loaded PEGylated liposomes in a rat model of Parkinson's disease.
    Yue P; Gao L; Wang X; Ding X; Teng J
    J Cell Biochem; 2018 Jun; 119(6):4581-4591. PubMed ID: 29240240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro.
    Hammond SL; Safe S; Tjalkens RB
    Neurosci Lett; 2015 Oct; 607():83-89. PubMed ID: 26383113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
    Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC
    Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contra-directional Coupling of Nur77 and Nurr1 in Neurodegeneration: A Novel Mechanism for Memantine-Induced Anti-inflammation and Anti-mitochondrial Impairment.
    Wei X; Gao H; Zou J; Liu X; Chen D; Liao J; Xu Y; Ma L; Tang B; Zhang Z; Cai X; Jin K; Xia Y; Wang Q
    Mol Neurobiol; 2016 Nov; 53(9):5876-5892. PubMed ID: 26497037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of a herbal extract combination of Bupleurum falcatum, Paeonia suffruticosa, and Angelica dahurica against MPTP-induced neurotoxicity via regulation of nuclear receptor-related 1 protein.
    Sim Y; Park G; Eo H; Huh E; Gu PS; Hong SP; Pak YK; Oh MS
    Neuroscience; 2017 Jan; 340():166-175. PubMed ID: 27771535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease.
    Sasaki T; Liu K; Agari T; Yasuhara T; Morimoto J; Okazaki M; Takeuchi H; Toyoshima A; Sasada S; Shinko A; Kondo A; Kameda M; Miyazaki I; Asanuma M; Borlongan CV; Nishibori M; Date I
    Exp Neurol; 2016 Jan; 275 Pt 1():220-31. PubMed ID: 26555088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson's Disease.
    Yu H; Liu X; Chen B; Vickstrom CR; Friedman V; Kelly TJ; Bai X; Zhao L; Hillard CJ; Liu QS
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA.
    Kuter K; Olech Ł; Głowacka U
    Mol Neurobiol; 2018 Apr; 55(4):3049-3066. PubMed ID: 28466266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noscapine Prevents Rotenone-Induced Neurotoxicity: Involvement of Oxidative Stress, Neuroinflammation and Autophagy Pathways.
    Jayaraj RL; Beiram R; Azimullah S; M F NM; Ojha SK; Adem A; Jalal FY
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson's Disease in Rats.
    Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
    Mol Neurobiol; 2018 May; 55(5):4078-4089. PubMed ID: 28585189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease.
    Xue YQ; Zhao LR; Guo WP; Duan WM
    Neuroscience; 2007 May; 146(3):1245-58. PubMed ID: 17363174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson's disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway.
    Kambey PA; Chengcheng M; Xiaoxiao G; Abdulrahman AA; Kanwore K; Nadeem I; Jiao W; Gao D
    Metab Brain Dis; 2021 Apr; 36(4):609-625. PubMed ID: 33507465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson's disease.
    Kim CH; Han BS; Moon J; Kim DJ; Shin J; Rajan S; Nguyen QT; Sohn M; Kim WG; Han M; Jeong I; Kim KS; Lee EH; Tu Y; Naffin-Olivos JL; Park CH; Ringe D; Yoon HS; Petsko GA; Kim KS
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8756-61. PubMed ID: 26124091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.
    Spathis AD; Asvos X; Ziavra D; Karampelas T; Topouzis S; Cournia Z; Qing X; Alexakos P; Smits LM; Dalla C; Rideout HJ; Schwamborn JC; Tamvakopoulos C; Fokas D; Vassilatis DK
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3999-4004. PubMed ID: 28348207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.